MedTrace Logo

Pre-sleep Protein Supplementation in British Army Recruits

NCT05998590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-08-21

No results posted yet for this study

Summary

Dietary protein has been shown to be important to support physical training. For occupational demands such as military training, new recruits often fail to meet the recommended protein intake during basic training (BT), with negligible amounts consumed in the evening. As such, individuals undertaking BT may require higher intakes than the general population.This study assessed the influence of a daily bolus of protein prior to sleep on performance adaptations, body composition and recovery in British Army recruits.

Conditions

  • Protein-energy; Imbalance
  • Recovery
  • Body Weight

Interventions

DIETARY_SUPPLEMENT

High protein supplement

The participants received a 60g protein bolus each evening prior to sleep from week 3 to week 12 of training.

DIETARY_SUPPLEMENT

Moderate protein supplement

The participants received a 20g protein bolus each evening prior to sleep from week 3 to week 12 of training.

DIETARY_SUPPLEMENT

Carbohydrate placebo

The participants received an isocaloric carbohydrate bolus each evening prior to sleep from week 3 to week 12 of training.

OTHER

Control: No supplementation

The participants did not receive any supplementation but instead acted as a control group doing BT only

Sponsors & Collaborators

  • University of Exeter

    collaborator OTHER

  • Anglia Ruskin University

    lead OTHER

Principal Investigators

  • Justin D Roberts, PhD · Anglia Ruskin University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05998590 on ClinicalTrials.gov